Literature DB >> 12774923

Pure red cell aplasia in a patient with trisomy X chromosome abnormality and reactivated Epstein-Barr virus infection.

Masanori Daibata1, Hisanori Machida, Yuiko Nemoto, Hirokuni Taguchi.   

Abstract

We describe a woman with a congenital chromosome anomaly, 47,XXX, who developed chronic pure red cell aplasia (PRCA). The patient had serologic reactivity consistent with that of reactivated Epstein-Barr virus (EBV) infection, as judged by high titers for anti-EBV viral capsid antigen (VCA) immunoglobulin G (IgG) and anti-early antigen (EA) IgG. Detection of EBV genome in peripheral blood cells and cell-free serum also supported the diagnosis. Although EBV infection has been implicated in the pathogenesis of acute PRCA, the viral infection rarely results in a chronic disease state. So far, only 1 case of EBV-associated chronic PRCA has been reported, to the best of our knowledge. Chronic PRCA also is known to occur on an autoimmune basis. Individuals carrying an extra X chromosome, such as XXY and XXX, are prone to development of immune abnormalities. Our patient had an anti-DNA autoantibody and a positive result of the direct Coombs test. The pathogenesis of PRCA in this case seemed to involve multiple factors. In addition to the infectious agent, host factors may have played a role. Although the etiologic link between chronic PRCA and trisomy X remains to be elucidated, our findings suggest the importance of karyotype analysis as well as search for infectious agents in patients with chronic PRCA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12774923     DOI: 10.1007/bf02982643

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  33 in total

Review 1.  Klinefelter's syndrome and systemic lupus erythematosus.

Authors:  W R Gilliland; M E Stashower
Journal:  Clin Exp Rheumatol       Date:  2000 Jan-Feb       Impact factor: 4.473

Review 2.  Parvovirus B19 for the hematologist.

Authors:  J W Harris
Journal:  Am J Hematol       Date:  1992-02       Impact factor: 10.047

3.  Clinical and virologic characteristics of chronic active Epstein-Barr virus infection.

Authors:  H Kimura; Y Hoshino; H Kanegane; I Tsuge; T Okamura; K Kawa; T Morishima
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

4.  Systemic lupus erythematosus and Klinefelter's syndrome.

Authors:  J W Marshall
Journal:  Am J Med       Date:  1988-01       Impact factor: 4.965

Review 5.  The chronic mononucleosis syndrome.

Authors:  S E Straus
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

Review 6.  Pure red cell aplasia in childhood and adolescence: pathogenesis and approaches to diagnosis.

Authors:  M H Freedman
Journal:  Br J Haematol       Date:  1993-10       Impact factor: 6.998

7.  Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo.

Authors:  N C Zoumbos; P Gascon; J Y Djeu; N S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

8.  Letter: Systemic lupus erythematosus and Klinefelter's syndrome.

Authors:  P R Burch; N R Rowell
Journal:  Lancet       Date:  1976-05-08       Impact factor: 79.321

9.  Autoimmunity in a patient with 47,XXX karyotype.

Authors:  D P Michalak; H A Zacur; J A Rock; J D Woodruff
Journal:  Obstet Gynecol       Date:  1983-11       Impact factor: 7.661

Review 10.  NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management.

Authors:  S E Straus; J I Cohen; G Tosato; J Meier
Journal:  Ann Intern Med       Date:  1993-01-01       Impact factor: 25.391

View more
  1 in total

1.  Persistent anemia in a patient with diffuse large B cell lymphoma: pure red cell aplasia associated with latent Epstein-Barr virus infection in bone marrow.

Authors:  Hwa Jung Sung; Seok Jin Kim; Ji Hye Lee; Goeun Lee; Kyung A Lee; Chul Won Choi; Byung Soo Kim; Jun Suk Kim
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.